Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-8448b6f56d-c4f8m Total loading time: 0 Render date: 2024-04-25T00:11:12.078Z Has data issue: false hasContentIssue false

Chapter 19 - Neonatal Thrombosis

from Section VI - Hemostatic Disorders

Published online by Cambridge University Press:  30 January 2021

By
Gary Woods  and
Matthew A. Saxonhouse
Edited by
Pedro A. de Alarcón ,
Eric J. Werner ,
Robert D. Christensen  and
Martha C. Sola-Visner
Pedro A. de Alarcón
Affiliation:
University of Illinois College of Medicine
Eric J. Werner
Affiliation:
Children's Hospital of the King's Daughters
Robert D. Christensen
Affiliation:
University of Utah
Martha C. Sola-Visner
Affiliation:
Harvard University, Massachusetts
Get access

Summary

Thromboembolism (TE) in pediatrics is relatively rare compared with adults, with an estimated venous thromboembolism (VTE) incidence of 0.07–0.14/10,000 children [1, 2]. A bimodal age distribution has been well demonstrated in the pediatric VTE population and children less than 1 year of age, especially those less than 1 month of age, are most commonly affected [1, 2]. The incidence of VTE in this very young population, particularly when hospitalized, is increasing [3–6]. Between 1997 and 2018, up to a 13-fold increase in neonatal TE incidence has been described in all live births and a greater than six-fold increase in neonatal TE incidence has been described for neonatal intensive care unit (NICU) admissions [4–7]. This increase has been attributed to improving survival rates in critically ill and/or premature neonates, the increased utilization of central venous catheters (CVC), and a much greater awareness of VTE and the associated risk factors in this population [3, 6, 8, 9]. The aim of this chapter is to review the congenital and acquired risk factors associated with neonatal TE and to discuss the clinical presentation, diagnosis, and management of this rare complication that has been shown to significantly impact the morbidity and mortality rates of those afflicted [1–3, 8].

Type
Chapter
Information
Neonatal Hematology
Pathogenesis, Diagnosis, and Management of Hematologic Problems
 , pp. 312 - 328
Publisher: Cambridge University Press
Print publication year: 2021

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Andrew, M, David, M, Adams, M, et al. Venous thromboembolic complications (VTE) in children: First analyses of the Canadian Registry of VTE. Blood 1994;83(5):1251–7.Google Scholar
van Ommen, CH, Heijboer, H, Büller, HR, et al. Venous thromboembolism in childhood: A prospective two-year registry in The Netherlands. J Pediatr 2001;139(5):676–81.Google Scholar
Raffini, L, Huang, YS, Witmer, C, Feudtner, C. Dramatic increase in venous thromboembolism in children’s hospitals in the United States from 2001 to 2007. Pediatrics 2009;124(4):1001–8.Google Scholar
Nowak-Gottl, U, von Kries, R, Gobel, U. Neonatal symptomatic thromboembolism in Germany: Two-year survey. Arch Dis Child Fetal Neonatal Ed, 1997;76(3):F163–7.CrossRefGoogle ScholarPubMed
Schmidt, B, Andrew, M. Neonatal thrombosis: Report of a prospective Canadian and international registry. Pediatrics 1995. 96(5 Pt 1):939–43.Google Scholar
Saracco, P, Bagna, R, Gentilomo, C, et al. Clinical data of neonatal systemic thrombosis. J Pediatr 2016;171:60–6 e1.Google Scholar
Bhat, R, Kumar, R, Kwon, S, Murthy, K, Liem, RI. Risk factors for neonatal venous and arterial thromboembolism in the neonatal intensive care unit: A case control study. J Pediatr 2018;195:28–32.Google Scholar
Setty, BA, O’Brien, SH, Kerlin, BA. Pediatric venous thromboembolism in the United States: A tertiary care complication of chronic diseases. Pediatr Blood Cancer 2012;59(2):258–64.Google Scholar
Nag, U, Greenberg, R, Leraas, HJ, et al. Risk factors for thrombosis in the neonatal intensive care unit: Analysis of a large national database. Blood 2017;130 (Supplement 1): 3351.Google Scholar
Monagle, P, Barnes, C, Ignjatovic, V, et al. Developmental haemostasis: Impact for clinical haemostasis laboratories. Thromb Haemost 2006;95(2):362–72.Google Scholar
Andrew, M, Paes, B, Milner, R, et al. Development of the human coagulation system in the full-term infant. Blood 1987;70(1):165–72.Google Scholar
Andrew, M, Paes, B, Milner, R, et al. Development of the human coagulation system in the healthy premature infant. Blood 1988;72(5):1651–7.Google Scholar
Attard, C, van der Straaten, T, Karlaftis, V, Monagle, P, Ignjatovic, V. Developmental hemostasis: Age-specific differences in the levels of hemostatic proteins. J Thromb Haemost 2013;11(10):1850–4.Google Scholar
Saxonhouse, MA, Manco-Johnson, MJ. The evaluation and management of neonatal coagulation disorders. Semin Perinatol 2009;33(1):52–65.Google Scholar
Saxonhouse, MA, Thrombosis in the neonatal intensive care unit. Clin Perinatol 2015;42(3):651–73.CrossRefGoogle ScholarPubMed
Schmidt, B, Zipursky, A. Thrombotic disease in newborn infants. Clin Perinatol 1984;11(2):461–88.Google Scholar
Beardsley, DS. Venous thromboembolism in the neonatal period. Semin Perinatol 2007;31(4):250–3.Google Scholar
Greenway, A, Massicotte, MP, Monagle, P. Neonatal thrombosis and its treatment. Blood Rev 2004;18(2):75–84.Google Scholar
Park, CK, Paes, BA, Nagel, K, et al. Neonatal central venous catheter thrombosis: Diagnosis, management and outcome. Blood Coagul Fibrinolysis 2014;25(2):97–106.Google Scholar
Pettit, J. Assessment of infants with peripherally inserted central catheters: Part 1. Detecting the most frequently occurring complications. Adv Neonatal Care 2002;2(6):304–15.Google Scholar
Rajagopal, R, Cheah, FC, Monagle, P. Thromboembolism and anticoagulation management in the preterm infant. Semin Fetal Neonatal Med 2016;21(1):50–6.Google Scholar
Narang, S, Roy, J, Stevens, TP, et al. Risk factors for umbilical venous catheter-associated thrombosis in very low birth weight infants. Pediatr Blood Cancer 2009;52(1):75–9.Google Scholar
Chalmers, EA. Perinatal stroke: Risk factors and management. Br J Haematol 2005;130(3):333–43.Google Scholar
Manco-Johnson, M. Controversies in neonatal thrombotic disorders. In Ohls R, YM, ed. Hematology, Immunology and Infections Disease: Neonatology Questions and Controversies (Philadelphia, PA: Saunders Elsevier, 2008), pp. 58–74.Google Scholar
Nelson, KB, Causative factors in cerebral palsy. Clin Obstet Gynecol 2008;51(4):749–62.CrossRefGoogle ScholarPubMed
Saracco, P, Parodi, C, Fabris, V, et al. Management and investigation of neonatal thromboembolic events: genetic and acquired risk factors. Thromb Res 2009; 123(6):805–9.Google Scholar
Klaassen, IL, van Ommen, CH, Middeldorp, S. Manifestations and clinical impact of pediatric inherited thrombophilia. Blood 2015;125(7):1073–7.Google Scholar
Demirel, N, Aydin, M, Zenciroglu, A, et al. Neonatal thrombo-embolism: Risk factors, clinical features and outcome. Ann Trop Paediatr 2009;29(4):271–9.Google Scholar
Salonvaara, M, Riikonen, P, Kekomäki, R, Heinonen, K. Clinically symptomatic central venous catheter-related deep venous thrombosis in newborns. Acta Paediatr 1999;88(6):642–6.CrossRefGoogle ScholarPubMed
O’Brien, SH. Perinatal thrombosis: Implications for mothers and neonates. Hematology Am Soc Hematol Educ Program 2015;2015:48–52.Google Scholar
Dahlback, B. The protein C anticoagulant system: Inherited defects as basis for venous thrombosis. Thromb Res 1995;77(1):1–43.Google Scholar
Dahlback, B. Inherited thrombophilia: Resistance to activated protein C as a pathogenic factor of venous thromboembolism. Blood 1995;85(3):607–14.CrossRefGoogle ScholarPubMed
van der Meer, FJ, Koster, T, Vandenbroucke, JP, Briët, E, Rosendaal, FR. The Leiden Thrombophilia Study (LETS). Thromb Haemost 1997;78(1):631–5.Google ScholarPubMed
Price, DT, Ridker, PM. Factor V Leiden mutation and the risks for thromboembolic disease: A clinical perspective. Ann Intern Med 1997;127(10):895–903.Google Scholar
Laugesaar, R, Kahre, T, Kolk, A, et al. Factor V Leiden and prothrombin 20210G>A mutation and paediatric ischaemic stroke: A case-control study and two meta-analyses. Acta Paediatr 2010;99(8):1168–74.Google Scholar
Poort, SR, Rosendaal, FR, Reitsma, PH, Bertina, RM. A common genetic variation in the 3‘-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88(10):3698–703.Google Scholar
Junker, R, Koch, HG, Auberger, K, et al. Prothrombin G20210A gene mutation and further prothrombotic risk factors in childhood thrombophilia. Arterioscler Thromb Vasc Biol 1999;19(10):2568–72.CrossRefGoogle ScholarPubMed
Allaart, CF, Poort, SR, Rosendaal, FR, et al. Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect. Lancet 1993;341(8838):134–8.CrossRefGoogle ScholarPubMed
Tridapalli, E, Stella, M, Capretti, MG, Faldella, G. Neonatal arterial iliac thrombosis in type-I protein C deficiency: a case report. Ital J Pediatr 2010;36:23.Google Scholar
De Stefano, V, Leone, G, Mastrangelo, S, et al. Clinical manifestations and management of inherited thrombophilia: retrospective analysis and follow-up after diagnosis of 238 patients with congenital deficiency of antithrombin III, protein C, protein S. Thromb Haemost 1994;72(3):352–8.Google Scholar
De Stefano, V, Finazzi, G, Mannucci, PM. Inherited thrombophilia: Pathogenesis, clinical syndromes, and management. Blood 1996;87(9):3531–44.Google Scholar
Auletta, MJ, Headington, JT. Purpura fulminans. A cutaneous manifestation of severe protein C deficiency. Arch Dermato, 1988;124(9):1387–91.Google Scholar
Adcock, DM, Brozna, J, Marlar, RA. Proposed classification and pathologic mechanisms of purpura fulminans and skin necrosis. Semin Thromb Hemost 1990;16(4):333–40.Google Scholar
Alessi, MC, Aillaud, MF, Paut, O, et al. Purpura fulminans in a patient homozygous for a mutation in the protein C gene–prenatal diagnosis in a subsequent pregnancy. Thromb Haemost 1996;75(3):525–6.Google Scholar
Marlar, RA, Montgomery, RR, Broekmans, AW. Report on the diagnosis and treatment of homozygous protein C deficiency. Report of the Working Party on Homozygous Protein C Deficiency of the ICTH-Subcommittee on Protein C and Protein S. Thromb Haemost 1989;61(3):529–31.Google Scholar
Dreyfus, M, Magny, JF, Bridey, F, et al. Treatment of homozygous protein C deficiency and neonatal purpura fulminans with a purified protein C concentrate. N Engl J Med 1991;325(22):1565–8.Google Scholar
Kroiss, S, Albisetti, M. Use of human protein C concentrates in the treatment of patients with severe congenital protein C deficiency. Biologics 2010;4:51–60.Google Scholar
Walker, FJ. Regulation of activated protein C by a new protein. A possible function for bovine protein S. J Biol Chem 1980;255(12):5521–4.Google Scholar
Moalic, P, Gruel, Y, Body, G, et al. Levels and plasma distribution of free and C4b-BP-bound protein S in human fetuses and full-term newborns. Thromb Res 1988;49(5):471–80.Google Scholar
Schwarz, HP, Muntean, W, Watzke, H, Richter, B, Griffin, JH. Low total protein S antigen but high protein S activity due to decreased C4b-binding protein in neonates. Blood 1988;71(3):562–5.Google Scholar
Pegelow, CH, Ledford, M, Young, J, Zilleruelo, G. Severe protein S deficiency in a newborn. Pediatrics 1992;89(4 Pt 1):674–6.Google Scholar
Hui, CH, Lam, CC, Sze, CS. A family of protein S deficiency including two adults with homozygous deficiency. Thromb Haemost 1997;78(3):1158–9.Google Scholar
Pung-amritt, P, Poort, SR, Vos, HL, et al. Compound heterozygosity for one novel and one recurrent mutation in a Thai patient with severe protein S deficiency. Thromb Haemost 1999;81(2):189–92.Google Scholar
Mahasandana, C, Suvatte, V, Chuansumrit, A, et al. Homozygous protein S deficiency in an infant with purpura fulminans. J Pediatr 1990;117(5):750–3.Google Scholar
Lane, DA, Caso, R. Antithrombin: structure, genomic organization, function and inherited deficiency. Baillieres Clin Haematol 1989;2(4):961–98.Google Scholar
Bjarke, B, Herin, P, Blomback, M. Neonatal aortic thrombosis. A possible clinical manifestation of congenital antithrombin 3 deficiency. Acta Paediatr Scand 1974;63(2):297–301.Google Scholar
Winter, JH, Fenech, A, Ridley, W, et al. Familial antithrombin III deficiency. Q J Med 1982;51(204):373–95.Google Scholar
Brenner, B, Fishman, A, Goldsher, D, Schreibman, D. Cerebral thrombosis in a newborn with a congenital deficiency of antithrombin III. Am J Hematol 1988;27(3):209–11.Google Scholar
Peeters, S, Vandenplas, Y, Jochmans, K, et al. Myocardial infarction in a neonate with hereditary antithrombin III deficiency. Acta Paediatr 1993;82(6–7):610–13.Google Scholar
Jochmans, K., Lissens, W, Vervoort, R, et al. Antithrombin-Gly 424 Arg: A novel point mutation responsible for type 1 antithrombin deficiency and neonatal thrombosis. Blood 1994;83(1):146–51.Google Scholar
Newman, RS, Spear, GS, Kirschbaum, N. Postmortem DNA diagnosis of factor V Leiden in a neonate with systemic thrombosis and probable antithrombin deficiency. Obstet Gynecol 1998;92(4 Pt 2):702–5.Google Scholar
Swoboda, V, Zervan, K, Thom, K, et al. Homozygous antithrombin deficiency type II causing neonatal thrombosis. Thromb Res 2017;158:134–7.Google Scholar
Chowdhury, V, Lane, DA, Mille, B, et al. Homozygous antithrombin deficiency: Report of two new cases (99 Leu to Phe) associated with arterial and venous thrombosis. Thromb Haemost 1994;72(2):198–202.Google ScholarPubMed
Roman, K, Rosenthal, E, Razavi, R. Pulmonary arterial thrombosis in a neonate with homozygous deficiency of antithrombin III: Successful outcome following pulmonary thrombectomy and infusions of antithrombin III concentrate. Cardiol Young 2000;10(3):275–8.Google Scholar
Shiozaki, A, Arai, T, Izumi, R, Niiya, K, Sakuragawa, N. Congenital antithrombin III deficient neonate treated with antithrombin III concentrates. Thromb Res 1993;70(3):211–16.Google Scholar
Gunther, G, Junker, R, Sträter, R, et al. Symptomatic ischemic stroke in full-term neonates: Role of acquired and genetic prothrombotic risk factors. Stroke 2000;31(10):2437–41.CrossRefGoogle ScholarPubMed
Nowak-Gottl, U, Junker, R, Hartmeier, M, et al. Increased lipoprotein(a) is an important risk factor for venous thromboembolism in childhood. Circulation 1999;100(7):743–8.Google Scholar
Gacio, S, Munoz Giacomelli, F, Klein, F. Presumed perinatal ischemic stroke: A review. Arch Argent Pediatr 2015;113(5):449–55.Google Scholar
Fernandez-Lopez, D, Natarajan, N, Ashwal, S, Vexler, ZS. Mechanisms of perinatal arterial ischemic stroke. J Cereb Blood Flow Metab 2014;34(6):921–32.Google Scholar
Hunt, RW, Inder, TE. Perinatal and neonatal ischaemic stroke: A review. Thromb Res 2006;118(1):39–48.Google Scholar
Lynch, JK, Nelson, KB. Epidemiology of perinatal stroke. Curr Opin Pediatr 2001;13(6):499–505.Google Scholar
Lynch, JK, Nelson, KB, Curry, CJ, Grether, JK. Cerebrovascular disorders in children with the factor V Leiden mutation. J Child Neurol 2001;16(10):735–44.Google Scholar
Elbers, J, Viero, S, MacGregor, D, DeVeber, G, Moore, AM. Placental pathology in neonatal stroke. Pediatrics 2011;127(3):e722–9.Google Scholar
Giacchetti, L, De Gaudenzi, M, Leoncini, A, et al. Neonatal renal and inferior vena cava thrombosis associated with fetal thrombotic vasculopathy: A case report. J Med Case Rep 2017;11(1):248.Google Scholar
Estan, J, Hope, P. Unilateral neonatal cerebral infarction in full term infants. Arch Dis Child Fetal Neonatal Ed 1997;76(2):F88–93.Google Scholar
Venkataraman, A, Kingsley, PB, Kalina, P, et al. Newborn brain infarction: Clinical aspects and magnetic resonance imaging. CNS Spectr 2004;9(6):436–44.Google Scholar
Lövblad, KO, el-Koussy, M, Guzman, R, et al. Diffusion-weighted and perfusion-weighted MR of cerebral vasospasm. Acta Neurochir Suppl 2001;77:121–6.Google Scholar
Mader, I, Schöning, M, Klose, U, Küker, W. Neonatal cerebral infarction diagnosed by diffusion-weighted MRI: Pseudonormalization occurs early. Stroke 2002;33(4):1142–5.Google Scholar
Mercuri, E., Cowan, F, Gupte, G, et al. Prothrombotic disorders and abnormal neurodevelopmental outcome in infants with neonatal cerebral infarction. Pediatrics 2001;107(6):1400–4.Google Scholar
Greenberg, R, Waldman, D, Brooks, C, et al. Endovascular treatment of renal artery thrombosis caused by umbilical artery catheterization. J Vasc Surg 1998;28(5):949–53.CrossRefGoogle ScholarPubMed
Nouri, S, Mahdhaoui, N, Beizig, S, et al. Thrombose aortique néonatale majeure: à propos d‘une observation [Major neonatal aortic thrombosis: A case report]. Arch Pediatr 2007;14(9):1097–100.Google Scholar
Seibert, JJ, Northington, FJ, Miers, JF, Taylor, BJ. Aortic thrombosis after umbilical artery catheterization in neonates: prevalence of complications on long-term follow-up. AJR Am J Roentgenol 1991;156(3):567–9.Google Scholar
Barrington, KJ. Umbilical artery catheters in the newborn: Effects of position of the catheter tip. Cochrane Database Syst Rev 2000;2:CD000505.Google Scholar
Barrington, KJ. Umbilical artery catheters in the newborn: Effects of heparin. Cochrane Database Syst Rev 2000;2:CD000507.Google Scholar
Bhat, R, Monagle, P. The preterm infant with thrombosis. Arch Dis Child Fetal Neonatal Ed 2012;97(6):F423–8.Google Scholar
Sellitto, M, Messina, F. Central venous catheterization and thrombosis in newborns: Update on diagnosis and management. J Matern Fetal Neonatal Med 2012;25(Suppl 4):26–8.Google Scholar
Sol, JJ, van de Loo, M, Boerma, M, et al. NEOnatal Central-venous Line Observational study on Thrombosis (NEOCLOT): Evaluation of a national guideline on management of neonatal catheter-related thrombosis. BMC Pediatr 2018;18(1):84.Google Scholar
van Elteren, HA, Veldt, HS, Te Pas, AB, et al. Management and outcome in 32 neonates with thrombotic events. Int J Pediatr 2011;2011:217564.Google Scholar
Khilnani, P, Goldstein, B, Todres, ID. Double lumen umbilical venous catheters in critically ill neonates: a randomized prospective study. Crit Care Med 1991;19(11):1348–51.Google Scholar
Tanke, RB, van Megen, R, Daniels, O. Thrombus detection on central venous catheters in the neonatal intensive care unit. Angiology 1994;45(6):477–80.Google Scholar
Monagle, P, Chan, AKC, Goldenberg, NA, et al. Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141(2 Suppl):e737S-801S.Google Scholar
O’Grady, NP, Alexander, M, Burns, LA, et al. Guidelines for the prevention of intravascular catheter-related infections. Infect Control Hosp Epidemiol 2002;23(12):759–69.Google Scholar
Saxonhouse, MA, Burchfield, DJ. The evaluation and management of postnatal thromboses. J Perinatol 2009;29(7):467–78.Google Scholar
Andrew, ME, Monagle, P, deVeber, G, Chan, AK. Thromboembolic disease and antithrombotic therapy in newborns. Hematology Am Soc Hematol Educ Program 2001;358–74.Google Scholar
Ulloa-Ricardez, A, Romero-Espinoza, L, Estrada-Loza Mde, J, González, -Cabello, HJ, Núñez-Enríquez, JC. Risk factors for intracardiac thrombosis in the right atrium and superior vena cava in critically ill neonates who required the installation of a central venous catheter. Pediatr Neonatol 2016;57(4):288–94.Google Scholar
Hermansen, MC, Hermansen, MG. Intravascular catheter complications in the neonatal intensive care unit. Clin Perinatol 2005;32(1):141–56, vii.Google Scholar
Torres-Valdivieso, MJ, Cobas, J, Barrio, C, et al. Successful use of tissue plasminogen activator in catheter-related intracardiac thrombus of a premature infant. Am J Perinatol 2003;20(2):91–6.Google Scholar
Cholette, JM, Rubenstein, JS, Alfieris, GM, et al. Elevated risk of thrombosis in neonates undergoing initial palliative cardiac surgery. Ann Thorac Surg 2007;84(4):1320–5.Google Scholar
Fenton, KN, Siewers, RD, Rebovich, B, Pigula, FA. Interim mortality in infants with systemic-to-pulmonary artery shunts. Ann Thorac Surg 2003;76(1):152–6; discussion 156–7.Google Scholar
Bidadi, B, Nageswara, Rao, AA, Kaur, D, Khan, SP, Rodriguez, V. Neonatal renal vein thrombosis: Role of anticoagulation and thrombolysis. An institutional review. Pediatr Hematol Oncol 2016;33(1):59–66.Google Scholar
Lau, KK, Stoffman, JM, Williams, S, et al. Neonatal renal vein thrombosis: Review of the English-language literature between 1992 and 2006. Pediatrics 2007;120(5):e1278–84.Google Scholar
Messinger, Y, Sheaffer, JW, Mrozek, J, Smith, CM, Sinaiko, AR. Renal outcome of neonatal renal venous thrombosis: Review of 28 patients and effectiveness of fibrinolytics and heparin in 10 patients. Pediatrics 2006;118(5):e1478–84.Google Scholar
Williams, S, Chan, AK. Neonatal portal vein thrombosis: Diagnosis and management. Semin Fetal Neonatal Med 2011;16(6):329–39.Google Scholar
deVeber, G, Andrew, M, Adams, C, et al. Cerebral sinovenous thrombosis in children. N Engl J Med 2001;345(6):417–23.CrossRefGoogle ScholarPubMed
Wasay, M, Dai, AI, Ansari, M, Shaikh, Z, Roach, ES. Cerebral venous sinus thrombosis in children: A multicenter cohort from the United States. J Child Neurol 2008;23(1):26–31.Google Scholar
Wu, YW, Hamrick, SE, Miller, SP, et al. Intraventricular hemorrhage in term neonates caused by sinovenous thrombosis. Ann Neurol 2003;54(1):123–6.Google Scholar
Manco-Johnson, MJ. How I treat venous thrombosis in children. Blood 2006;107(1):21–9.Google Scholar
Berfelo, FJ, Kersbergen, KJ, van Ommen, CH, et al. Neonatal cerebral sinovenous thrombosis from symptom to outcome. Stroke 2010;41(7):1382–8.CrossRefGoogle ScholarPubMed
Kersbergen, KJ, Groenendaal, F, Benders, MJ, et al. The spectrum of associated brain lesions in cerebral sinovenous thrombosis: relation to gestational age and outcome. Arch Dis Child Fetal Neonatal Ed 2011;96(6):F404–9.Google Scholar
Moharir, MD, Shroff, M, Pontigon, AM, et al. A prospective outcome study of neonatal cerebral sinovenous thrombosis. J Child Neurol 2011;26(9):1137–44.Google Scholar
Monagle, P, Cuello, CA, Augustine, C, et al. American Society of Hematology 2018 Guidelines for management of venous thromboembolism: Treatment of pediatric venous thromboembolism. Blood Advances 2018;2(22):3291–316.Google Scholar
Bendaly, EA, Batra, AS, Ebenroth, ES, Hurwitz, RA. Outcome of cardiac thrombi in infants. Pediatr Cardiol 2008;29(1):95–101.Google Scholar
Butler-O’Hara, M, Buzzard, CJ, Reubens, L, et al. A randomized trial comparing long-term and short-term use of umbilical venous catheters in premature infants with birth weights of less than 1251 grams. Pediatrics 2006;118(1):e25–35.Google Scholar
Kim, JH, Lee, YS, Kim, SH, et al. Does umbilical vein catheterization lead to portal venous thrombosis? Prospective US evaluation in 100 neonates. Radiology 2001;219(3):645–50.Google Scholar
Bacciedoni, V Attie, M, Donato, H, Comité Nacional de Hematología, Oncología y Medicina Transfusional. Thrombosis in newborn infants. Arch Argent Pediatr 2016;114(2):159–66.Google Scholar
van der Aa, NE, Benders, MJ, Groenendaal, F, de Vries, LS. Neonatal stroke: A review of the current evidence on epidemiology, pathogenesis, diagnostics and therapeutic options. Acta Paediatr 2014;103(4):356–64.Google Scholar
Saxonhouse, MA. Management of neonatal thrombosis. Clin Perinatol 2012;39(1):191–208.Google Scholar
Marks, KA, Zucker, N, Kapelushnik, J, Karplus, M, Levitas, A. Infective endocarditis successfully treated in extremely low birth weight infants with recombinant tissue plasminogen activator. Pediatrics 2002;109(1):153–8.Google Scholar
Rossor, T, Arichi, T, Bhate, S, Hart, AR, Raman Singh, R. Anticoagulation in the management of neonatal cerebral sinovenous thrombosis: A systematic review and meta-analysis. Dev Med Child Neurol 2018;60(9):884–891.Google Scholar
Kerlin, BA, Blatt, NB, Fuh, B, et al. Epidemiology and risk factors for thromboembolic complications of childhood nephrotic syndrome: A Midwest Pediatric Nephrology Consortium (MWPNC) study. J Pediatr 2009;155(1):105–10, 110 e1.Google Scholar
Young, G. Old and new antithrombotic drugs in neonates and infants. Semin Fetal Neonatal Med 2011;16(6):349–54.Google Scholar
Chan, AK, Monagle, P. Updates in thrombosis in pediatrics: Where are we after 20 years? Hematology Am Soc Hematol Educ Program 2012;2012:439–43.Google Scholar
Bounameaux, H. Unfractionated versus low-molecular-weight heparin in the treatment of venous thromboembolism. Vasc Med 1998;3(1):41–6.Google Scholar
Samama, MM, Gerotziafas, GT. Comparative pharmacokinetics of LMWHs. Semin Thromb Hemost 2000;26(Suppl 1):31–8.Google Scholar
Malowany, JI, Knoppert, DC, Chan, AK, Pepelassis, D, Lee, DS. Enoxaparin use in the neonatal intensive care unit: Experience over 8 years. Pharmacotherapy 2007;27(9):1263–71.Google Scholar
Malowany, JI, Monagle, P, Knoppert, DC, et al. Enoxaparin for neonatal thrombosis: A call for a higher dose for neonates. Thromb Res 2008;122(6):826–30.Google Scholar
Bhatt, MD, Paes, BA, Chan, AK. How to use unfractionated heparin to treat neonatal thrombosis in clinical practice. Blood Coagul Fibrinolysis 2016;27(6):605–14.Google Scholar
Hartmann, J, Hussein, A, Trowitzsch, E, Becker, J, Hennecke, KH. Treatment of neonatal thrombus formation with recombinant tissue plasminogen activator: six years’ experience and review of the literature. Arch Dis Child Fetal Neonatal Ed 2001;85(1):F18–22.Google Scholar
Wang, M, Hays, T, Balasa, V, et al. Low-dose tissue plasminogen activator thrombolysis in children. J Pediatr Hematol Oncol 2003;25(5):379–86.Google Scholar
Zenz, W, Arlt, F, Sodia, S, Berghold, A. Intracerebral hemorrhage during fibrinolytic therapy in children: a review of the literature of the last thirty years. Semin Thromb Hemost 1997;23(3):321–32.Google Scholar
Alioglu, B, Ozyurek, E, Tarcan, A, et al. Heterozygous methylenetetrahydrofolate reductase 677C-T gene mutation with mild hyperhomocysteinemia associated with intrauterine iliofemoral artery thrombosis. Blood Coagul Fibrinolysis 2006;17(6):495–8.Google Scholar
Boffa, MC, Lachassinne, E. Infant perinatal thrombosis and antiphospholipid antibodies: a review. Lupus 2007;16(8):634–41.Google Scholar
Kenet, G, Nowak-Gottl, U. Fetal and neonatal thrombophilia. Obstet Gynecol Clin North Am 2006;33(3):457–66.Google Scholar
Kosch, A, Kuwertz, -Bröking, E, Heller, C, et al. Renal venous thrombosis in neonates: Prothrombotic risk factors and long-term follow-up. Blood 2004;104(5):1356–60.CrossRefGoogle ScholarPubMed
Lee, J, Croen, LA, Backstrand, KH, et al. Maternal and infant characteristics associated with perinatal arterial stroke in the infant. JAMA 2005;293(6):723–9.Google Scholar
Nowak, -Göttl, U, Duering, C, Kempf, -Bielack, B, Sträter, R. Thromboembolic diseases in neonates and children. Pathophysiol Haemost Thromb 2003;33(5–6):269–74.Google Scholar
Raju, TN, Nelson, KB, Ferriero, D, Lynch, JK, NICHD-NINDS Perinatal Stroke Workshop Participants. Ischemic perinatal stroke: Summary of a workshop sponsored by the National Institute of Child Health and Human Development and the National Institute of Neurological Disorders and Stroke. Pediatrics 2007;120(3):609–16.Google Scholar
Wu, YW, Lynch, JK, Nelson, KB. Perinatal arterial stroke: understanding mechanisms and outcomes. Semin Neurol 2005;25(4):424–34.Google Scholar
Kenet, G, Lütkhoff, LK, Albisetti, M, et al. Impact of thrombophilia on risk of arterial ischemic stroke or cerebral sinovenous thrombosis in neonates and children: A systematic review and meta-analysis of observational studies. Circulation 2010;121(16):1838–47.Google Scholar
Rosendaal, FR. Venous thrombosis: The role of genes, environment, and behavior. Hematology Am Soc Hematol Educ Program, 2005:1–12.Google Scholar
Marks, SD, Massicotte, MP, Steele, BT, et al. Neonatal renal venous thrombosis: Clinical outcomes and prevalence of prothrombotic disorders. J Pediatr 2005;146(6):811–16.Google Scholar
Thornburg, C, Pipe, S. Neonatal thromboembolic emergencies. Semin Fetal Neonatal Med 2006;11(3):198–206.Google Scholar
Molinari, AC, Banov, L, Bertamino, M, et al. A practical approach to the use of low molecular weight heparins in VTE treatment and prophylaxis in children and newborns. Pediatr Hematol Oncol, 2015;32(1):1–10.Google Scholar
Armstrong-Wells, JM, Manco-Johnson MJ. Neonatal thrombosis. In De Alarcón, PW, Werner, EJ, Christensen, RD, eds. Neonatal Hematology (New York: Cambridge University Press, 2013), p. 282.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×